投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
暂无数据
年文章数
505
NCBI查询
偏重的研究方向
暂无数据
期刊简介
稿件收录要求
稿件收录要求
lzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access journal that concentrates on the discovery, development, and validation of assays, instruments, and technologies with the potential to facilitate accurate detection of dementia in its various forms and stages. Of particular interest are promising dementia biomarkers, ranging from gene expression and proteomic markers, to imaging, cognitive and functional markers of disease progression or treatment response. Review our Author Guidelines and submit your manuscript to DADM.
DADM is now indexed in the Emerging Sources Citation Index (ESCI).
Reasons to Publish with Us:
- Easy to follow Author Guidelines with expedient time to first decision and online publication.
- Broad editorial team allows us to match your article with a skilled reviewer in your content area.
- Open Access format makes your research free to read and share, with author copyright retention.
- Publishes high-interest Special Topic Sections anually, and has a CiteScore over 7.
